The tumour hypoxia marker pimonidazole reflects a transcriptional programme associated with aggressive prostate cancer

BACKGROUND: The hypoxia marker pimonidazole is a candidate biomarker of cancer aggressiveness. We investigated the transcriptional programme associated with pimonidazole staining in prostate cancer. METHODS: Index tumour biopsies were taken by image guidance from an investigation cohort of 52 patien...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Br J Cancer
Autors principals: Ragnum, H B, Vlatkovic, L, Lie, A K, Axcrona, K, Julin, C H, Frikstad, K M, Hole, K H, Seierstad, T, Lyng, H
Format: Artigo
Idioma:Inglês
Publicat: Nature Publishing Group 2015
Matèries:
Molecular Diagnostics
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4453458/
https://ncbi.nlm.nih.gov/pubmed/25461803
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2014.604
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars